NCT06354712View on ClinicalTrials.gov

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions

Oral Mucositis (Ulcerative) Due to Radiation

Interventions

DRUG

N-Acetyl-Cysteine with Institutional standard care

A potent antioxidant and anti-inflammatory drug (A precursor of the endogenous antioxidant glutathione)

DRUG

Institutional standard care

Benzydamine Mouthwash

Trial Locations (1)

Unknown

RECRUITING

Clinical Oncology and Nuclear Medicine of Mansoura University Hospital, Al Mansurah

All Listed Sponsors

lead

Mansoura University

OTHER

NCT06354712 - Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients. | Biotech Hunter | Biotech Hunter